Press Releases

February 25th, 2019 Baptist Health South Florida

Miami Cancer Institute Names Horacio Asbun, M.D., FACS, Chief of Heptobiliary and Pancreatic Surgery

Dr. Asbun HeadshotMIAMI, FL – February 25, 2019 – Surgeon Horacio Asbun, M.D., FACS, has joined Miami Cancer Institute, the region’s premier cancer treatment and research destination and part of Baptist Health South Florida. Dr. Asbun will serve as Chief of Hepatobiliary and Pancreatic Surgery for Miami Cancer Institute and throughout Baptist Health. He brings to the role more than 25 years of surgical experience treating cancers and complex diseases of the liver, pancreas, adrenals, gallbladder and biliary system. Dr. Asbun will combine world-class patient care with leading-edge research to provide highly effective, personalized treatment options for patients with pancreatic and biliary disease. The Pancreatic and Liver Disease Program also draws on expertise from the fields of surgery, interventional radiology, oncology, hepatology, interventional oncology, gastroenterology, diagnostic radiology, interventional gastroenterology, radiation therapy, anesthesia and pain management to deliver seamless multidisciplinary care under one roof.  

“Dr. Asbun is a renowned surgeon and clinical researcher. His addition to the Institute’s Pancreatic Disease Program distinguishes it as a world-class program,” said Michael J. Zinner, M.D., chief executive officer and executive medical director of Miami Cancer Institute. “Our patients will have access to the latest and most sophisticated therapies tailored to treat specific types of tumors and receive comprehensive treatment that focuses on the whole person to achieve the best-possible outcomes and improved quality of life.”  

Dr. Asbun received his medical degree from the University of Chile in Santiago, Chile. His postdoctoral training includes a general surgery fellowship at Hospital de La Santa Cruz y San Pablo, Autonomous University, in Barcelona, Spain, and a surgical oncology fellowship at the University of California at San Diego. Following this training, he completed a general surgery residency at Kern Medical Center in Bakersfield, CA, University of San Diego California associated program. He also completed a fellowship in gastrointestinal, hepatobiliary and pancreas surgery at Lahey Clinic in Burlington, MA. He is Board certified by the American Board of Surgery.

Prior to joining Miami Cancer Institute, Dr. Asbun served as professor of Surgery at Mayo Clinic College of Medicine and chairman of General Surgery and director of the Hepatobiliary and Pancreas Program at Mayo Clinic Florida, which he joined in 2008.

Throughout his career, Dr. Asbun has repeatedly been named a Top Doctor by U.S. News & World Report and Castle Connelly Ltd. He conducts collaborative clinical research to improve treatment efficacy and patient outcomes. He has published more than 150 scientific articles, 110 peer reviewed surgical videos and 35 book chapters in his specialty. He also serves as editor-in-chief of the American College of Surgeons Multimedia Atlas, has edited six surgical books, is a reviewer for numerous scientific journals.

Dr. Asbun directs and teaches national courses on surgery and speaks frequently at scientific conferences around the world, with more than 650 presentations to date in the United States and in over six continents. In addition to being a Fellow of the American College of Surgeons, he is a member of multiple surgical societies and serves on the Boards and committees of several national and international professional societies, including the Society of American Gastrointestinal and Endoscopic Surgeons, Americas Hepato-Pancreato-Biliary Association and the Global Alliance for Surgical, Obstetric, Trauma and Anesthesia Care (G4 alliance).  

About Miami Cancer Institute
Baptist Health South Florida is developing Miami Cancer Institute into a destination cancer center known for its leading clinical care, compassionate patient experience, advanced clinical research and state-of-the-art technology – including the first proton therapy center in South Florida, Latin America and the Caribbean. To accelerate its mission of hope, caring and innovation, Miami Cancer Institute has joined the Memorial Sloan Kettering Cancer Alliance, a meaningful partnership that affords patients with cancer access to potential breakthrough therapies in South Florida. For more information, visit MiamiCancerInstitute.com.

Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with ten hospitals (Baptist Hospital, Baptist Children’s Hospital, Bethesda Hospital East, Bethesda Hospital West, Doctors Hospital, Fishermen’s Community Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital), more than 40 physician practices, 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence spanning across Monroe, Miami-Dade, Broward and Palm Beach counties. A not-for-profit organization supported by philanthropy and committed to our faith-based charitable mission of medical excellence, Baptist Health has approximately 18,500 employees and more than 3,000 affiliated physicians. Baptist Health South Florida has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/newsroom and connect with us on Facebook at facebook.com/BaptistHealthSF and on Twitter and Instagram @BaptistHealthSF.

###


Media Assets

Filename Size
Dr.-Asbun-Headshot.jpg 1.48 Mb

Contact Us

For media inquiries, please contact us via email at MediaRelations@BaptistHealth.net or call
(754) 900-9967.
Share
By using this Site, I agree to it's Terms & Conditions. All content downloaded form the Site (photography, audio and video, etc.) may be used for editorial purposes only. Any other use of Site content including without limitation personal or commercial use, is strictly prohibited.